LINDA ZERBY: Open Payments
NPI 1164673836 · CHARLEVOIX, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $168 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Corium, LLC | 1 | $29 |
| PFIZER INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, INSPIRE, Azstarys, UBRELVY, PAXLOVID, Ozempic, FARXIGA.
Industry payments across MI — which companies pay providers there.
